Next-Generation SARS-CoV-2 Vaccine Formulations and Alternative Routes of Administration

Tara M Babu; Lisa A Jackson; Hana M El Sahly

doi:10.1093/infdis/jiae504

Next-Generation SARS-CoV-2 Vaccine Formulations and Alternative Routes of Administration

J Infect Dis. 2024 Oct 16:jiae504. doi: 10.1093/infdis/jiae504. Online ahead of print.

Authors

Tara M Babu¹, Lisa A Jackson², Hana M El Sahly³

Affiliations

¹ Department of Medicine, Division of Allergy and Infectious Diseases, University of Washington Seattle, WA, USA.
² Kaiser Permanente Washington Health Research Institute, Seattle, WA, USA.
³ Departments of Molecular Virology and Microbiology and Medicine, Section of Infectious Diseases, Baylor College of Medicine, Houston, TX, USA.

PMID: 39412209
DOI: 10.1093/infdis/jiae504

Abstract

The development of SARS-CoV-2 next-generation vaccines with the potential for increased effectiveness, durability, breadth, and ability to decrease transmission are of public health importance. We highlight alternative routes of administration of next-generation SARS-CoV-2 vaccines such as mucosal and intradermal administration.

Keywords: COVID-19; SARS-CoV-2; next-generation; vaccines.

© The Author(s) 2024. Published by Oxford University Press on behalf of Infectious Diseases Society of America. All rights reserved. For commercial re-use, please contact [email protected] for reprints and translation rights for reprints. All other permissions can be obtained through our RightsLink service via the Permissions link on the article page on our site—for further information please contact [email protected].